Publication:
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella pneumoniae Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK

dc.contributor.authorBleriot, Ines
dc.contributor.authorBlasco, Lucia
dc.contributor.authorDelgado-Valverde, Mercedes
dc.contributor.authorGual-de-Torella, Ana
dc.contributor.authorAmbroa, Anton
dc.contributor.authorFernandez-Garcia, Laura
dc.contributor.authorLopez, Maria
dc.contributor.authorOteo-Iglesias, Jesus
dc.contributor.authorWood, Thomas K.
dc.contributor.authorPascual, Alvaro
dc.contributor.authorBou, German
dc.contributor.authorFernandez-Cuenca, Felipe
dc.contributor.authorTomas, Maria
dc.contributor.authoraffiliation[Bleriot,I; Blasco,L; Ambroa,A; Fernandez-Garcia,L; Lopez,M; Bou,G; Tomas,M] Microbiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain. [Bleriot,I; Blasco,L; Fernandez-Garcia,L; Oteo-Iglesias,J; Pascual,A; Bou,G; Fernandez-Cuenca,F; Tomas,M] Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain. [Delgado-Valverde,M; Gual-de-Torella,A; Pascual,A; Fernandez-Cuenca,F] Clinical Unit for Infectious Diseases, Department of Microbiology and Medicine, Microbiology and Preventive Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicine Insititute of Seville (IBIS), Seville, Spain. [Lopez,M; Oteo-Iglesias,J; Pascual,A; Bou,G; Fernandez-Cuenca,F; Tomas,M] Spanish Network for Research in Infectious Diseases (REIPI), Seville, Spain. [Oteo-Iglesias,J] Reference and Research Laboratory for Antibiotic Resistance and Health Care Infections, National Centre for Microbiology, Institute of Health Carlos III, Majadahonda, Spain. [Wood,TK] Department of Chemical Engineering, Pennsylvania State University, University Park, PA, USA.
dc.contributor.funderThis study was funded by grants PI16/01163 and PI19/00878 awarded to M. Tomás within the State Plan for R+D+I 2013–2016 (National Plan for Scientific Research, Technological Development and Innovation 2008–2011) and co-financed by the ISCIII-Deputy General Directorate for Evaluation and Promotion of Research - European Regional Development Fund “A way of Making Europe” and Instituto de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases (REIPI, RD16/0016/0001, RD16/CIII/0004/0002 and RD16/0016/0006) and by the Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC, http://www.seimc.org/).
dc.date.accessioned2022-06-27T09:32:14Z
dc.date.available2022-06-27T09:32:14Z
dc.date.issued2020-09-02
dc.description.abstractAlthough the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this study we analyzed the molecular mechanisms associated with chlorhexidine adaptation in two clinical strains of Klebsiella pneumoniae by phenotypic and transcriptomic studies. These two strains belong to ST258-KPC3 (high-risk clone carrying β-lactamase KPC3) and ST846-OXA48 (low-risk clone carrying β-lactamase OXA48). Our results showed that the K. pneumoniae ST258-KPC3CA and ST846-OXA48CA strains exhibited a different behavior under chlorhexidine (CHLX) pressure, adapting to this biocide through resistance and tolerance mechanisms, respectively. Furthermore, the appearance of cross-resistance to colistin was observed in the ST846-OXA48CA strain (tolerant to CHLX), using the broth microdilution method. Interestingly, this ST846-OXA48CA isolate contained a plasmid that encodes a novel type II toxin/antitoxin (TA) system, PemI/PemK. We characterized this PemI/PemK TA system by cloning both genes into the IPTG-inducible pCA24N plasmid, and found their role in persistence and biofilm formation. Accordingly, the ST846-OXA48CA strain showed a persistence biphasic curve in the presence of a chlorhexidine-imipenem combination, and these results were confirmed by the enzymatic assay (WST-1).es_ES
dc.description.versionYeses_ES
dc.identifier.citationBleriot I, Blasco L, Delgado-Valverde M, Gual de Torella A, Ambroa A, Fernandez-Garcia L, et al. Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella pneumoniae Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK. Toxins. 2020 Sep 2;12(9):566es_ES
dc.identifier.doi10.3390/toxins12090566es_ES
dc.identifier.essn2072-6651
dc.identifier.pmcPMC7551900
dc.identifier.pmid32887507es_ES
dc.identifier.urihttp://hdl.handle.net/10668/3709
dc.journal.titleToxins
dc.language.isoen
dc.page.number17 p.
dc.publisherMDPIes_ES
dc.relation.publisherversionhttps://www.mdpi.com/2072-6651/12/9/566/htmes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectTolerancees_ES
dc.subjectPersistencees_ES
dc.subjectCross-resistancees_ES
dc.subjectToxin-antitoxin systemes_ES
dc.subjectPemI/PemKes_ES
dc.subjectKlebsiella pneumoniaees_ES
dc.subjectCombinación de medicamentoses_ES
dc.subjectFarmacorresistencia bacterianaes_ES
dc.subjectSistemas toxina-antitoxinaes_ES
dc.subjectTranscriptomaes_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agentses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Infective Agents, Locales_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Bacterial Proteinses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amidines::Guanidines::Biguanides::Chlorhexidinees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinationses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Pharmacological Processes::Drug Tolerancees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Carbapenems::Thienamycins::Imipenemes_ES
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Klebsiella::Klebsiella pneumoniaees_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physical Phenomena::Time::Time Factorses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamaseses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacteriales_ES
dc.subject.meshToxin-Antitoxin Systemses_ES
dc.titleMechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella pneumoniae Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIKes_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Bleriot_MechanismsOfTolerance.pdf
Size:
1.68 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Loading...
Thumbnail Image
Name:
Bleriot_MechanismsOfTolerance_MaterialSuplementario.pdf
Size:
309.37 KB
Format:
Adobe Portable Document Format
Description:
Material suplementario